Prospective Study of Sinonasal and Skull-base Tumours Management
Launched by UNIVERSITY MEDICAL CENTRE LJUBLJANA · Nov 3, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying patients with tumors and diseases affecting the nose and the base of the skull. The goal is to gather information about how common these conditions are, how well different treatments work, and how they impact patients' quality of life. Researchers at a specialized center are looking to understand more about these patients by observing their cases and collecting data over time.
To participate in this study, patients should have sinonasal (nose-related) or skull-base cancer, or a sinonasal disease that is affecting the skull base. Importantly, they must also be willing to give their written consent to be part of the study. Participants can expect to be monitored by healthcare professionals, and their experiences and outcomes will contribute to a better understanding of these conditions. This research is currently in the recruiting stage and is open to all eligible patients, regardless of age or gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • sinonasal and/or skull-base cancer
- • sinonasal disease expanding through the skull-base
- • the patient's written informed consent
- Exclusion Criteria:
- • lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement
About University Medical Centre Ljubljana
University Medical Centre Ljubljana (UMCL) is a leading academic medical institution in Slovenia, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMCL integrates cutting-edge medical practices with comprehensive patient care, fostering an environment of collaboration among healthcare professionals, researchers, and patients. With a strong emphasis on ethical standards and scientific integrity, UMCL aims to contribute to the global body of medical knowledge while improving treatment outcomes in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ljubljana, , Slovenia
Patients applied
Trial Officials
Domen Vozel, MD, PhD
Study Director
University Medical Centre Ljubljana
Jure Urbančič, MD
Study Director
University Medical Centre Ljubljana
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials